LEAH UMBEHANT: Open Payments
NPI 1336403435 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,472 in 89 payments from 17 companies in 2025. Trend: 2023 $1,838 · 2024 $2,053 · 2025 $1,472
Food & beverage: $1,472
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $381 |
| Novartis Pharmaceuticals Corporation | 13 | $223 |
| LEO Pharma Inc. | 6 | $161 |
| Galderma Laboratories, L.P. | 12 | $156 |
| GENZYME CORPORATION | 4 | $123 |
| PFIZER INC. | 6 | $113 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $53 |
| Amgen Inc. | 2 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
Products named: RINVOQ, SKYRIZI, COSENTYX, DUPIXENT, NEMLUVIO, ADBRY, CIBINQO, ANZUPGO.
Industry payments across GA — which companies pay providers there.
